MONA: Assessments of Dietary Restrictions in Young and Elderly Obese Men : Metabolism Obesity Nutrition Age
Study Details
Study Description
Brief Summary
The prevalence of obesity is growing in elderly with heavy consequences in term of medical complications and mortality, so that this is nowadays an important public health issue.
The major therapeutic solution is dietary restrictions, but and the advantages and the metabolic consequences are not well known in elderly. The MONA study main aim is to assess the metabolic changes in this population, after dietary restrictions, compared to young people.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Primary endpoint : Study the metabolic adaptations of the subcutaneous adipose tissue after a diet in elderly obese men compared to young obese men.
Secondary endpoints : Study the metabolic adaptations of skeletal muscle, the genetic adaptations of subcutaneous adipose tissue and skeletal muscle, the inflammatory and fibrosis modifications of subcutaneous adipose tissue, the insulinosensibility modifications, the modifications on the physical composition, modifications of the energy expenditure in resting state and the oxidation of the substrata, study the lipoproteins metabolism and identify new biomarkers. All those endpoints are studied comparing elderly obese subjects versus young obese subjects.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: obese men from 60 to 70 years old Dietary restrictions in obese men (30<Body Mass Index<40 kg/m2) |
Other: dietary restrictions
Dietary restrictions during 8 weeks
Other Names:
|
Active Comparator: obese men from 30 to 40 years old Dietary restrictions in obese men (30<Body Mass Index<40 kg/m2) |
Other: dietary restrictions
Dietary restrictions during 8 weeks
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Lipolysis at resting and during physical activity test [Change after 8 weeks dietary restrictions]
Determine lipolysis at resting and during physical activity test by microdialysis, before dietary restrictions and after dietary restrictions (20% dietary restrictions)
Secondary Outcome Measures
- Metabolic parameters in skeletal muscle [Change after 8 weeks dietary restrictions]
To assess metabolic parameters before dietary restrictions and after dietary restrictions (20 % dietary restrictions)
- Genetic markers [Change after 8 weeks dietary restrictions]
To assess genetic markers in adipose tissue and skeletal tissue before dietary restrictions and after dietary restrictions
- Fibrosis and inflammatory markers in adipose tissue [Change after 8 weeks dietary restrictions]
To assess markers in adipose tissue before dietary restrictions and after dietary restrictions (20 % dietary restrictions)
- insulinosensibility [Change after 8 weeks dietary restrictions]
To determine insulinosensibility before dietary restrictions and after dietary restrictions (20 % dietary restrictions)
- Fat and muscles rates in the whole body [Change after 8 weeks dietary restrictions]
To determine fat and muscles rates by Dexa before dietary restrictions and after dietary restrictions
- Energetic consumption [Change after 8 weeks dietary restrictions]
energetic consumption at resting and during physical activity, before dietary restrictions and after dietary restrictions
- Lipoproteins metabolism [Change after 8 weeks dietary restrictions]
Before dietary restrictions and after dietary restrictions
- biomarkers identification [Change after 8 weeks dietary restrictions]
New urinary and intestinal biomarkers identification, before dietary restrictions and after dietary restrictions
Eligibility Criteria
Criteria
Inclusion Criteria:
-
30 < years old < 40 OR 60 < years old < 70
-
obesity : 30 < BMI < 40
-
stable blood pressure (diastolic <90mmHg, systolic < 140mmHg)
-
glycemia < 1,26g/L, LDL cholest <1,9-1,6g/L, Triglycerides <2,5g/L
-
risk factors concerning high blood pressure, diabetes and dyslipidemia under control
Exclusion Criteria:
-
Insulin dependent diabetes, non-insulin dependent diabetes
-
high blood pressure
-
dyslipidemia
-
history of cardiovascular diseases or bariatric surgery
-
undernutrition
-
HbA1C >7%
-
non authorized treatments : Glucagon-like peptide-1 agonists,
-
incapacity to do physical activity
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital Toulouse | Toulouse | France | 31 059 |
Sponsors and Collaborators
- University Hospital, Toulouse
Investigators
- Principal Investigator: Claire Thalamas, MD PhD, University Hospital, Toulouse
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 13 149 03
- 2013-A01543-42